Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 58602-844

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 58602-844). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (1 x 5 Blister Carton)

Packaging label for Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets USP 180 mg/240 mg by Aurohealth LLC. The label indicates 5 film-coated, extended-release tablets for oral use, providing 24-hour relief from allergy and congestion symptoms. The product is labeled as non-drowsy and includes usage information, warnings, and drug facts.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.